Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dose Reduction and Discontinuation of Biologic and Targeted Synthetic disease‐modifying Anti‐rheumatic Drugs (DMARDs) in People With Axial Spondyloarthritis and Low Disease Activity." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438173/all/images/. Accessed 12 June 2024.
Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/all/images/. Accessed June 12, 2024.
Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/all/images/
Dose Reduction and Discontinuation of Biologic and Targeted Synthetic disease‐modifying Anti‐rheumatic Drugs (DMARDs) in People With Axial Spondyloarthritis and Low Disease Activity [Internet]. In: Cochrane Abstracts. [cited 2024 June 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/all/images/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity
ID - 438173
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/all/images/
DB - Evidence Central
DP - Unbound Medicine
ER -